Evidence for discrete stages of human natural killer cell differentiation in vivo.
Human natural killer (NK) cells originate from CD34(+) hematopoietic progenitor cells, but the discrete stages of NK cell differentiation in vivo have not been elucidated. We identify and functionally characterize, from human lymph nodes and tonsils, four NK cell developmental intermediates spanning the continuum of differentiation from a CD34(+) NK cell progenitor to a functionally mature NK cell. Analyses of each intermediate stage for CD34, CD117, and CD94 cell surface expression, lineage differentiation potentials, capacity for cytokine production and natural cytotoxicity, and ETS-1, GATA-3, and T-BET expression provide evidence for a new model of human NK cell differentiation in secondary lymphoid tissues.
Freud
Aharon G
AG
Medical Scientist Program, The Ohio State University, Columbus, OH 43210, USA.
Yokohama
Akihiko
A
Becknell
Brian
B
Lee
Melissa T
MT
Mao
Hsiaoyin C
HC
Ferketich
Amy K
AK
Caligiuri
Michael A
MA
D015415:Biomarkers; D002454:Cell Differentiation / Q000276:immunology*; D019070:Cell Lineage / Q000276:immunology; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis; D003601:Cytotoxicity Tests, Immunologic; D020869:Gene Expression Profiling; D006801:Humans; D007694:Killer Cells, Natural / Q000166:cytology* / Q000276:immunology / Q000378:metabolism; D008198:Lymph Nodes / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D014066:Palatine Tonsil / Q000166:cytology / Q000276:immunology / Q000378:metabolism
D015415:Biomarkers; D016207:Cytokines